Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mercedes Robledo

Showing results (61-70 of 215) with videos related to

Pageof 22
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2018
Biallelic <i>TSC2</i> Mutations in a Patient With Chromophobe Renal Cell Carcinoma Showing Extraordinary Response to TemsirolimusPablo Maroto, Georgia Anguera, Juan Maria Roldan-Romero, et al.
European Journal of Internal Medicine|August 22, 2019
3P association (3PAs): Pituitary adenoma and pheochromocytoma/paraganglioma. A heterogeneous clinical syndrome associated with different gene mutationsFernando Guerrero-Pérez, Carmen Fajardo, Elena Torres Vela, et al.
Genes, Chromosomes & Cancer|December 21, 2004
A novel candidate region linked to development of both pheochromocytoma and head/neck paragangliomaAlberto Cascón, Sergio Ruiz-Llorente, Sandra Rodríguez-Perales, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2017
Exceptional Response to Temsirolimus in a Metastatic Clear Cell Renal Cell Carcinoma With an Early Novel <i>MTOR</i>-Activating MutationJuan Francisco Rodríguez-Moreno, María Apellaniz-Ruiz, Juan María Roldan-Romero, et al.
Blood|July 20, 2007
Expression of CYP3A4 as a predictor of response to chemotherapy in peripheral T-cell lymphomasCristina Rodríguez-Antona, Susanna Leskelä, Magdalena Zajac, et al.
Cancers|May 31, 2019
Targeting Cyclooxygenase-2 in Pheochromocytoma and Paraganglioma: Focus on Genetic BackgroundMartin Ullrich, Susan Richter, Verena Seifert, et al.
Genes, Chromosomes & Cancer|November 1, 2005
Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: a possible hot spot?Alberto Cascón, Cristina Montero-Conde, Sergio Ruiz-Llorente, et al.
Endocrine-Related Cancer|May 24, 2008
Evaluation of a functional epigenetic approach to identify promoter region methylation in phaeochromocytoma and neuroblastomaCaroline D E Margetts, Mark Morris, Dewi Astuti, et al.
Human Genetics|December 3, 2005
Evaluating HapMap SNP data transferability in a large-scale genotyping project involving 175 cancer-associated genesGloria Ribas, Anna González-Neira, Antonio Salas, et al.
Archivos Argentinos De Pediatria|July 18, 2020
Assessment of emergency trolley drugs in a children's hospital. Before and after study on an educational interventionMaría I Fernández Achával, Luis F Mammi, Nicolás Fortini Cabarcos, et al.
Pageof 22

Showing results (61-70 of 215) with videos related to

Sort By:
Pageof 22
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2018
Biallelic <i>TSC2</i> Mutations in a Patient With Chromophobe Renal Cell Carcinoma Showing Extraordinary Response to TemsirolimusPablo Maroto, Georgia Anguera, Juan Maria Roldan-Romero, et al.
European Journal of Internal Medicine|August 22, 2019
3P association (3PAs): Pituitary adenoma and pheochromocytoma/paraganglioma. A heterogeneous clinical syndrome associated with different gene mutationsFernando Guerrero-Pérez, Carmen Fajardo, Elena Torres Vela, et al.
Genes, Chromosomes & Cancer|December 21, 2004
A novel candidate region linked to development of both pheochromocytoma and head/neck paragangliomaAlberto Cascón, Sergio Ruiz-Llorente, Sandra Rodríguez-Perales, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2017
Exceptional Response to Temsirolimus in a Metastatic Clear Cell Renal Cell Carcinoma With an Early Novel <i>MTOR</i>-Activating MutationJuan Francisco Rodríguez-Moreno, María Apellaniz-Ruiz, Juan María Roldan-Romero, et al.
Blood|July 20, 2007
Expression of CYP3A4 as a predictor of response to chemotherapy in peripheral T-cell lymphomasCristina Rodríguez-Antona, Susanna Leskelä, Magdalena Zajac, et al.
Cancers|May 31, 2019
Targeting Cyclooxygenase-2 in Pheochromocytoma and Paraganglioma: Focus on Genetic BackgroundMartin Ullrich, Susan Richter, Verena Seifert, et al.
Genes, Chromosomes & Cancer|November 1, 2005
Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: a possible hot spot?Alberto Cascón, Cristina Montero-Conde, Sergio Ruiz-Llorente, et al.
Endocrine-Related Cancer|May 24, 2008
Evaluation of a functional epigenetic approach to identify promoter region methylation in phaeochromocytoma and neuroblastomaCaroline D E Margetts, Mark Morris, Dewi Astuti, et al.
Human Genetics|December 3, 2005
Evaluating HapMap SNP data transferability in a large-scale genotyping project involving 175 cancer-associated genesGloria Ribas, Anna González-Neira, Antonio Salas, et al.
Archivos Argentinos De Pediatria|July 18, 2020
Assessment of emergency trolley drugs in a children's hospital. Before and after study on an educational interventionMaría I Fernández Achával, Luis F Mammi, Nicolás Fortini Cabarcos, et al.
Pageof 22